English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

From pyrazolones to azaindoles : evolution of active-site SHP2 inhibitors based on scaffold hopping and bioisosteric replacement

MPS-Authors
/persons/resource/persons217567

Shanina,  Elena
Christoph Rademacher, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121753

Rademacher,  Christoph
Christoph Rademacher, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mostinski, Y., Heynen, G. J. J. E., López-Alberca, M. P., Paul, J., Miksche, S., Radetzki, S., et al. (2020). From pyrazolones to azaindoles: evolution of active-site SHP2 inhibitors based on scaffold hopping and bioisosteric replacement. Journal of Medicinal Chemistry, 63(23), 14780-14804. doi:10.1021/acs.jmedchem.0c01265.


Cite as: https://hdl.handle.net/21.11116/0000-0007-7565-4
Abstract
There is no abstract available